Cargando…

An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury

BACKGROUND: Oxaliplatin-based chemotherapy has been linked to the development of sinusoidal obstruction syndrome (SOS), which is detrimental to outcome after liver resection for colorectal liver metastases (CLM). The aim of this study was to determine how the expression of genes involved in the tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Stuart M, Mann, Jelena, Manas, Derek M, Mann, Derek A, White, Steven A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731578/ https://www.ncbi.nlm.nih.gov/pubmed/23458185 http://dx.doi.org/10.1111/hpb.12010

Ejemplares similares

Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis
por: Robinson, Stuart M., et al.
Publicado: (2012)

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
por: Hardy, Timothy, et al.
Publicado: (2017)

Epigenetics in liver disease
por: Mann, Derek A
Publicado: (2014)

Non-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer Cells
por: Corbett, Laura, et al.
Publicado: (2015)

A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision‐Cut Liver Slices
por: Paish, Hannah L., et al.
Publicado: (2019)

Epigenetics in liver disease: from biology to therapeutics
por: Hardy, Timothy, et al.
Publicado: (2016)

Histone Methyltransferase ASH1 Orchestrates Fibrogenic Gene Transcription During Myofibroblast Transdifferentiation
por: Perugorria, Maria Jesus, et al.
Publicado: (2012)

Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
por: Zeybel, Müjdat, et al.
Publicado: (2015)

Response to 'Comment on 'The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome''
por: Robinson, S M, et al.
Publicado: (2016)

The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome
por: Robinson, S M, et al.
Publicado: (2013)

Pharmacogenomic Determinants of Interindividual Drug Response Variability: From Discovery to Implementation
por: Scott, Stuart A., et al.
Publicado: (2021)

Epigenetic reprogramming in liver fibrosis and cancer()
por: Wilson, Caroline L., et al.
Publicado: (2017)

Research Progress of Pharmacogenomics in Drug-Induced Liver Injury
por: Shao, Qihui, et al.
Publicado: (2021)

The NF-κB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes
por: Elsharkawy, Ahmed M., et al.
Publicado: (2010)

Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
por: Xu, Jingyu, et al.
Publicado: (2021)

Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis
por: Zarate, R, et al.
Publicado: (2010)

A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse
por: Moles, Anna, et al.
Publicado: (2014)

Epigenetics and Liver Fibrosis
por: Moran-Salvador, Eva, et al.
Publicado: (2017)

Localized and triggered release of oxaliplatin for the treatment of colorectal liver metastasis
por: Gogineni, Venkateswara R, et al.
Publicado: (2020)

Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia
por: Breaux, Samantha, et al.
Publicado: (2020)

Pharmacogenomics arrives
por: Petsko, Gregory A
Publicado: (2004)

Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)

Pharmacogenomics in epilepsy
por: Balestrini, Simona, et al.
Publicado: (2018)

Pharmacogenomics
Publicado: (2008)

Pharmacogenomics
Publicado: (2008)

Encircling the regions of the pharmacogenomic landscape that determine drug response
por: Fernández-Torras, Adrià, et al.
Publicado: (2019)

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura A., et al.
Publicado: (2021)

Public Attitudes toward Pharmacogenomic Testing and Establishing a Statewide Pharmacogenomics Database in the State of Minnesota
por: Zhang, Lusi, et al.
Publicado: (2022)

Is there a role of pharmacogenomics in Africa
por: Matimba, A., et al.
Publicado: (2016)

Liver expression quantitative trait loci: a foundation for pharmacogenomic research
por: Glubb, Dylan M., et al.
Publicado: (2012)

Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver
por: Klein, Kathrin, et al.
Publicado: (2010)

SB Driver Analysis: a Sleeping Beauty cancer driver analysis framework for identifying and prioritizing experimentally actionable oncogenes and tumor suppressors
por: Newberg, Justin Y, et al.
Publicado: (2018)

Serotonin paracrine signaling in tissue fibrosis()()
por: Mann, Derek A., et al.
Publicado: (2013)

The PXR is a drug target for chronic inflammatory liver disease()
por: Wallace, Karen, et al.
Publicado: (2010)

Allele-Specific Regulation of Matrix Metalloproteinase-3 Gene by Transcription Factor NFκB
por: Souslova, Veronika, et al.
Publicado: (2010)

Variant Histone H2afv reprograms DNA methylation during early zebrafish development
por: Madakashira, Bhavani, et al.
Publicado: (2017)

RNA sequencing reveals changes in the microRNAome of transdifferentiating hepatic stellate cells that are conserved between human and rat
por: Sabater, Laura, et al.
Publicado: (2020)

A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics
por: Mizzi, Clint, et al.
Publicado: (2016)

Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL
por: Amin, Shilu, et al.
Publicado: (2012)

Pharmacogenomics of chemotherapeutic susceptibility and toxicity
por: Moen, Erika L, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cko50tk8m3afco2b07oecqa71o